• Log Out Log In
  • T. Rowe Price Health Sciences Fund (PRHSX)
    Ticker Symbol:
    PRHSX
    Fund Status:
    Open to new Retail investors  /  Open to subsequent Retail investments
    Fund Composition
    Asset Allocation
    as of 09/30/2014
    Domestic Stock 88.9%
    Foreign Stock 7.5%
    Cash 3.4%
    Convertibles 0.3%
    Foreign Bonds 0.0%
    Preferreds 0.0%
    Options -0.1%
    Volatility and Other Measures
    as of 09/30/2014
    Beta 0.88
    0.45
    Standard Deviation 13.62
    Price/Earnings Ratio (Domestic) 19.5
    Earnings Growth Rate (Domestic) 13.8
    Turnover Rate 36.6
    Median Market
    Capitalization
    $28,722.6 Million
    10 Largest Holdings
    Represents 34.36 % of Total Net Assets
    View Holdings as of:
    Actavis plc
    Aetna
    Alexion Pharmaceuticals
    Allergan Inc/United States
    Biogen Idec
    Gilead Sciences
    McKesson
    Puma Biotechnology
    UnitedHealth Group
    Valeant Pharmaceuticals International
    As of 09/30/2014 the Health Sciences Fund had a total of 154 holdings.
    Sector Diversification
    as of 09/30/2014
    % of Total Net Assets
    Biotechnology 31.7%
    Services 24.1%
    Pharmaceuticals 22.5%
    Products & Devices 10.6%
    Life Sciences 5.0%
    Miscellaneous 2.7%
    See Glossary for additional details on all data elements.